Assistant Professor of Pediatrics
Vanderbilt University Medical Center
Disclosure(s): AstraZeneca: Advisor/Consultant; NIH: Grant/Research Support
Dr. Antoon is a NIH-funded clinical and health services researcher with a program focused on pharmacoepidemiology and medication safety in the pediatric population. As a physician-scientist, Dr. Antoon designs and conducts pragmatic clinical trials and population-based observational studies of medications, with a focus on the treatment of respiratory illness (e.g., pneumonia, influenza, COVID-19, RSV) in children. He evaluates the relationship between serious adverse events and medication exposures, as well as determining the role of drug-drug interactions and underlying infections in the development of serious adverse events in children. Dr. Antoon’s studies have investigated medication-related neurologic and psychiatric adverse events, severe cutaneous adverse reactions (e.g., Stevens Johnson Syndrome), cardiac events, and anaphylactic allergic reactions, among others.